We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors That Underscore Primoris' Solid Growth Prospects
Read MoreHide Full Article
Primoris Services Corporation’s (PRIM - Free Report) strategic acquisitions, solid backlog level and operational excellence bode well. The acquisition of Willbros Group, Inc. (“Willbros”), on Jun 1, 2018, has been driving its revenues significantly.
Although shares of the company have underperformed the industry so far this year, earnings estimates for the current year have moved 1.8% upward in the past 60 days, reflecting analysts’ optimism surrounding bottom-line growth potential.
Let’s delve deeper into the factors that substantiate its Zacks Rank #2 (Buy).
Acquisition & Joint Venture Bode Well: Primoris rides high on solid acquisition strategy. On Jun 1, 2018, Primoris had acquired Willbros, a specialty energy infrastructure contractor serving oil and gas, and power industries. Willbros’ Utility Transmission & Distribution business enhanced Primoris’ Master Service Agreement (“MSA”) revenue base. The Canadian operating centers of Willbros expanded Primoris’ services in Western Canada. The Oil & Gas Facilities business improved offerings in the company’s existing markets.
In the first quarter, Willbros contributed approximately 23.8% to total revenues and $7.6 million to gross profit. Notably, total revenues of $661.6 million increased 31.2% from a year ago.
Additionally, the company own a 50% interest in the Carlsbad Power Constructors joint venture (“Carlsbad”) and 50% interest in the “ARB Inc. & B&M Engineering Co.” joint venture (“Wilmington”). Both the joint ventures are engineering and constructing gas-fired power generation facilities based in Southern California. These joint ventures helped it in the completion of a large power plant construction project in the Mid-Atlantic region and a methane plant project in Texas.
For full-year 2019, the company’s revenues are projected at $3.1 billion, up 5.5% year over year.
Robust Backlog to Drive Revenues: Primoris is poised to gain from its solid backlog position across businesses. As of Mar 31, 2019, the company achieved a record backlog of $2.94 billion, reflecting an increase of 6.5% from the comparable prior-year period. This marks the highest backlog in its history, reflecting strong end-market demand from both fixed and MSA for 2019 and beyond. Notably, it expects to realize approximately 80% of the backlog in the next four quarters.
Strength in Pipeline Segment: The Pipeline segment has been gaining considerable strength over the last few quarters. The segment specializes in a range of services including pipeline construction, pipeline maintenance, pipeline facility work, compressor stations, pump stations, metering facilities, and other services across the United States.
In the first quarter, the segment’s revenues grew an impressive 134.1% year over year, backed by progress on major pipeline projects in the Mid-Atlantic and West Texas, increased pipeline maintenance activity, along with positives from the acquisition of Willbros.
Solid Cost Management: Over the last few quarters, the company has been undertaking cost-control measures to boost profitability. Markedly, during the first quarter, it reduced SG&A expenses to nearly 6.5% of revenues compared with 7.3% in the prior-year period. Solid cost management helped it to generate higher profits. In the first quarter, the company generated adjusted earnings of 4 cents, four times higher than the year-ago period.
Notably, for full-year 2019, it anticipates earnings between $1.60 and $1.80 per share, up from $1.50 recorded in 2018.
Superior ROE: Primoris’ return on equity ("ROE") supports its growth potential. The company's ROE of 13.9% compares favorably with the industry's average of 12.3%, implying that it is efficient in using its shareholders' funds.
MasTec surpassed earnings estimates in all the trailing four quarters, with the average being 11.2%.
Great Lakes and Quanta Services’ earnings for the current year are expected to increase 300% and 29.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Factors That Underscore Primoris' Solid Growth Prospects
Primoris Services Corporation’s (PRIM - Free Report) strategic acquisitions, solid backlog level and operational excellence bode well. The acquisition of Willbros Group, Inc. (“Willbros”), on Jun 1, 2018, has been driving its revenues significantly.
Although shares of the company have underperformed the industry so far this year, earnings estimates for the current year have moved 1.8% upward in the past 60 days, reflecting analysts’ optimism surrounding bottom-line growth potential.
Let’s delve deeper into the factors that substantiate its Zacks Rank #2 (Buy).
Acquisition & Joint Venture Bode Well: Primoris rides high on solid acquisition strategy. On Jun 1, 2018, Primoris had acquired Willbros, a specialty energy infrastructure contractor serving oil and gas, and power industries. Willbros’ Utility Transmission & Distribution business enhanced Primoris’ Master Service Agreement (“MSA”) revenue base. The Canadian operating centers of Willbros expanded Primoris’ services in Western Canada. The Oil & Gas Facilities business improved offerings in the company’s existing markets.
In the first quarter, Willbros contributed approximately 23.8% to total revenues and $7.6 million to gross profit. Notably, total revenues of $661.6 million increased 31.2% from a year ago.
Additionally, the company own a 50% interest in the Carlsbad Power Constructors joint venture (“Carlsbad”) and 50% interest in the “ARB Inc. & B&M Engineering Co.” joint venture (“Wilmington”). Both the joint ventures are engineering and constructing gas-fired power generation facilities based in Southern California. These joint ventures helped it in the completion of a large power plant construction project in the Mid-Atlantic region and a methane plant project in Texas.
For full-year 2019, the company’s revenues are projected at $3.1 billion, up 5.5% year over year.
Robust Backlog to Drive Revenues: Primoris is poised to gain from its solid backlog position across businesses. As of Mar 31, 2019, the company achieved a record backlog of $2.94 billion, reflecting an increase of 6.5% from the comparable prior-year period. This marks the highest backlog in its history, reflecting strong end-market demand from both fixed and MSA for 2019 and beyond. Notably, it expects to realize approximately 80% of the backlog in the next four quarters.
Strength in Pipeline Segment: The Pipeline segment has been gaining considerable strength over the last few quarters. The segment specializes in a range of services including pipeline construction, pipeline maintenance, pipeline facility work, compressor stations, pump stations, metering facilities, and other services across the United States.
In the first quarter, the segment’s revenues grew an impressive 134.1% year over year, backed by progress on major pipeline projects in the Mid-Atlantic and West Texas, increased pipeline maintenance activity, along with positives from the acquisition of Willbros.
Solid Cost Management: Over the last few quarters, the company has been undertaking cost-control measures to boost profitability. Markedly, during the first quarter, it reduced SG&A expenses to nearly 6.5% of revenues compared with 7.3% in the prior-year period. Solid cost management helped it to generate higher profits. In the first quarter, the company generated adjusted earnings of 4 cents, four times higher than the year-ago period.
Notably, for full-year 2019, it anticipates earnings between $1.60 and $1.80 per share, up from $1.50 recorded in 2018.
Superior ROE: Primoris’ return on equity ("ROE") supports its growth potential. The company's ROE of 13.9% compares favorably with the industry's average of 12.3%, implying that it is efficient in using its shareholders' funds.
Other Key Picks
Other top-ranked stocks in the Construction sector include MasTec, Inc. (MTZ - Free Report) , Great Lakes Dredge & Dock Corp. (GLDD - Free Report) , and Quanta Services, Inc. (PWR - Free Report) . While MasTec sports a Zacks Rank #1 (Strong Buy), both Great Lakes and Quanta Services carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
MasTec surpassed earnings estimates in all the trailing four quarters, with the average being 11.2%.
Great Lakes and Quanta Services’ earnings for the current year are expected to increase 300% and 29.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>